Seres Therapeutics, Inc. Tax Withholding Paid on Stock Awards
Seres Therapeutics, Inc. (MCRB) reported Tax Withholding Paid on Stock Awards of $197.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2021-03-02
- Seres Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-12-31 was $1.00K.
- Seres Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-09-30 was -$1.00K.
- Seres Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-06-30 was $0.00.
- Seres Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2018-03-31 was $197.00K.
- Seres Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2018 was $197.00K, a 496.97% increase from fiscal 2017.
- Seres Therapeutics, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2017 was $33.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $0.00 derived: sum of 2 quarters · filed 2021-03-02 | $0.00 derived: sum of 3 quarters · filed 2021-03-02 | $197.00K 10-K · filed 2021-03-02 |
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$1.00K derived: sum of 2 quarters · filed 2019-11-05 | $196.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $197.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $197.00K 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $33.00K 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |